Status:
COMPLETED
Myo-inositol Versus D-chiro-inositol in the Treatment of Polycystic Ovary Syndrome and Insulin Resistance: Evaluation of Clinical, Metabolic, Endocrine and Ultrasound Parameters
Lead Sponsor:
AGUNCO Obstetrics and Gynecology Centre
Conditions:
PCOS
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
Insulin resistance has important implications in the pathogenesis of the polycystic ovary syndrome (PCOS) and insulin-sensitizing drugs are considered a useful therapeutic approach. Reduction of insu...
Eligibility Criteria
Inclusion
- Women fulfilled two out of three diagnostic criteria for PCOS
Exclusion
- Women with pre-existing secondary endocrine disorders
- Women with personal history of hypertension, diabetes mellitus or cardiovascular disorders
- Women who received treatment with other drugs for the previous 6 months before entering the study.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01514942
Last Update
January 23 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto di Patologia Ostetrica e Ginecologica
Catania, Italy